financetom
Business
financetom
/
Business
/
Toll Brothers Expected to Miss on Orders, Meet Gross Margin Target in Fiscal Q3, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toll Brothers Expected to Miss on Orders, Meet Gross Margin Target in Fiscal Q3, RBC Says
Aug 19, 2024 1:57 PM

04:41 PM EDT, 08/19/2024 (MT Newswires) -- Toll Brothers ( TOL ) fiscal Q3 results may miss on orders and match or top forecasts on gross margins, RBC Capital Markets said Monday in a report.

"We see downside to our orders estimate given misses across peers as well as the deceleration in broader demand data over the last several months," RBS said. Management remains confident on margins, though continued pricing weakness may pose risks for fiscal 2025, RBC analysts said.

Earnings in Q3 are estimated at $3.31 a share, in line with the consensus, and fiscal Q4 EPS is expected at $4 versus the Street's $4.06, RBC said. Homebuilding revenue is estimated at $2.7 billion, trailing the Street's $2.73 billion estimate, with deliveries at 2,810 units, below the consensus of 2,849, RBC said.

RBC rates Toll Brothers ( TOL ) as outperform. Results for Q3 are scheduled for Tuesday.

Shares of Toll Brothers ( TOL ) rose 0.2% in after-hours trading after gaining 3.4% in the regular session Monday.

Price: 133.65, Change: +0.03, Percent Change: +0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved